Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

327 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches.
Li W, Sakamuri RM, Lyons DE, Orcullo FM, Shinde V, Dela Pena EL, Maghanoy AA, Mallari IB, Tan EV, Nath I, Brennan PJ, Balagon M, Vissa V. Li W, et al. Among authors: shinde v. Antimicrob Agents Chemother. 2011 Nov;55(11):5384-7. doi: 10.1128/AAC.05236-11. Epub 2011 Aug 22. Antimicrob Agents Chemother. 2011. PMID: 21859943 Free PMC article.
LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.
Marcinek P, Jha AN, Shinde V, Sundaramoorthy A, Rajkumar R, Suryadevara NC, Neela SK, van Tong H, Balachander V, Valluri VL, Thangaraj K, Velavan TP. Marcinek P, et al. Among authors: shinde v. PLoS One. 2013 Aug 28;8(8):e73103. doi: 10.1371/journal.pone.0073103. eCollection 2013. PLoS One. 2013. PMID: 24015287 Free PMC article. Clinical Trial.
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial.
Shinde V, Lombard Koen A, Hoosain Z, Archary M, Bhorat Q, Fairlie L, Lalloo U, Masilela MSL, Moodley D, Hanley S, Fouche LF, Louw C, Tameris M, Singh N, Goga A, Dheda K, Grobbelaar C, Joseph N, Lombaard JJ, Mngqibisa R, Bhorat AE, Benadé G, Lalloo N, Pitsi A, Vollgraaff PL, Luabeya A, Esmail A, Petrick FG, Oommen Jose A, Foulkes S, Ahmed K, Thombrayil A, Kalonji D, Cloney-Clark S, Zhu M, Bennett C, Albert G, Marcheschi A, Plested JS, Neal S, Chau G, Cho I, Fries L, Glenn GM, Madhi SA; 2019nCoV-501 Study Group. Shinde V, et al. Hum Vaccin Immunother. 2024 Dec 31;20(1):2425147. doi: 10.1080/21645515.2024.2425147. Epub 2024 Dec 12. Hum Vaccin Immunother. 2024. PMID: 39666396 Free article. Clinical Trial.
A Modified Novel Validated High-Throughput Hemagglutinin Inhibition Assay Using Recombinant Virus-like Particles and Human Red Blood Cells for the Objective Evaluation of Recombinant Hemagglutinin Nanoparticle Seasonal Influenza Vaccine.
Vincent TS, Zhu M, Parekh A, Patel U, Cloney-Clark S, Klindworth A, Silva D, Gorinson A, Miranda K, Wang M, Longacre Z, Zhou B, Cho I, Cai R, Kalkeri R, Fries L, Shinde V, Plested JS. Vincent TS, et al. Among authors: shinde v. Microorganisms. 2024 Nov 19;12(11):2358. doi: 10.3390/microorganisms12112358. Microorganisms. 2024. PMID: 39597746 Free PMC article.
Rare Pathology: Choristoma of the Palatine Tonsil in Otorhinolaryngology.
Parab SR, Lashkari S, Asodiya V, Khan MM, Zope R, Ingale MH, Shinde V. Parab SR, et al. Among authors: shinde v. Indian J Otolaryngol Head Neck Surg. 2024 Oct;76(5):4728-4734. doi: 10.1007/s12070-024-04805-6. Epub 2024 Jun 20. Indian J Otolaryngol Head Neck Surg. 2024. PMID: 39376304
327 results